Allogeneic BCMA-targeting CAR T cells in relapsed/refractory multiple myeloma: phase 1 UNIVERSAL trial interim results
Sham Mailankody, Jeffrey Matous, Saurabh Chhabra, Michaela Liedtke, Surbhi Sidana, Olalekan O. Oluwole, Shahbaz A. Malik, Rajneesh Nath, Faiz Anwer, José Carlos Cruz, Myo Htut, Erin E. Karski, Wade Lovelace, Myles Dillon, Eric Butz, Wendy Ying, Arun Balakumaran, Shaji Kumar
Topics & Concepts
MedicineFludarabineCytokine release syndromeCyclophosphamideRegimenAdverse effectTolerabilityInternal medicineRefractory (planetary science)OncologyGastroenterologyImmunologySurgeryImmunotherapyChemotherapyCancerChimeric antigen receptorPhysicsAstrobiologyCAR-T cell therapy researchMultiple Myeloma Research and TreatmentsImmunotherapy and Immune Responses